Er 169
9.39 d
β- 0.3
γ 110...
e-

Chemical properties

Er-169 is a radiolanthanide, usually in trivalent state. The ionic radius of Er3+ is 89 pm, i.e. just 3% larger than Lu3+, which explains that chelators suitable for Lu-177 can be directly employed for Er-169 too, in particular DOTA.

Nuclear properties

Er-169 decays by β- emission with a half-life of 9.392(18) days to stable Tm-169. In addition to β- emission it shows emission of low energy conversion and Auger electrons REF, thus emitting in total about 1.45 electrons (with energies above 6 keV) per decay. However, γ-ray and X-ray emissions are very weak.

The mean electron energy emitted per decay is 103 keV, and the mean photon energy per decay is <1 keV REF.

Production

Er-169 is produced by thermal neutron bombardment of enriched Er-168 oxide targets in the high flux reactors of the production facilities: RHF at ILL or MARIA at NCBJ. Off-line mass separation from stable Er-168 is performed at the CERN-MEDICIS facility.

Distribution

Mass-separated radionuclides will be shipped from CERN-MEDICIS to the users in the form of ErCl3 solution or in solid form, implanted into NaCl, Al or Zn layer on a metallic foil.

Purity grades available

research/preclinical

No carrier added (n.c.a.)

Yes
ParameterSpecifications
Production routeEr-168(n,γ)Er-169
DaughterDecays to stable Tm-169: 100% β-
Half-life9.39 d
ProcessingOff-line mass separation + 2-step column separation
Primary Container2.5 mL borosilicate glass V-vial with silicon rubber screw cap, 5.0 mL borosilicate glass V-vial with silicone rubber screw cap (liquid samples) or20 mL borosilicate glass vial with Al foil screw cap (solid samples) from MEDICIS.
Product Graden.c.a. (but not in theoretical molar activity)
Physical FormSolid or Liquid
Chemical FormIn 0.05 – 0.1 M HCl
Radioactive Concentration (gamma spectrometry)n.a.
AppearanceClear solution
Radionuclide identification (gamma spectrometry)Presence of 110 keV gamma line
Radionuclidic Purity (gamma spectrometry)>99%
Chemical purity (ICP-OES)n.a.
Molar activity (ICP-OES)n.a.
Apparent Molar ActivityLabelling at 10 MBq/nmol PSMA-617
Microbiological qualityn.a.
Bacterial endotoxinn.a.
pH (pH strips)n.a.
Additional information
Activity available100 MBq few times per year, depends on reactor and MEDICIS schedule
Activity limit for UN2910 (excepted package) shipment1 GBq in dry state or 0.1 GBq in liquid form
Other informationResearch grade implanted in Al, Zn or NaCl layer on Au foil also possible

Applications

  • β-therapy

Point of supply

  • Geneva, Switzerland/France

Involved production facilities

ILL, International
NCBJ, Poland
CERN, International

Involved biomedical facilities

To find out in which biomedical facilities you can use this radionuclide, contact the helpdesk.

Helpdesk